SNYR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Synergy CHC Corp (SNYR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has potential market opportunities as highlighted by analysts, the lack of significant positive trading trends, weak financial performance in the latest quarter, and bearish technical indicators suggest that it is better to wait for clearer signs of improvement before investing.
The stock's MACD is positive but contracting, RSI is neutral at 25.883, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 1.257 and 1.205, with resistance at 1.425 and 1.477. The stock has a 20% chance of declining in the short term based on similar candlestick patterns.
The company has a Buy rating from Ascendiant analyst Edward Woo with a $5 price target, citing large market opportunities for its brain health supplement FOCUSfactor.
No significant trading trends from hedge funds or insiders. Financial performance in Q3 2025 shows a sharp decline in net income (-84.01% YoY) and EPS (-90.00% YoY). No recent news or congress trading data to indicate positive momentum.
In Q3 2025, revenue increased by 12.40% YoY to $8,010,112, but net income dropped by 84.01% YoY to $125,327, and EPS fell by 90.00% YoY to 0.01. Gross margin improved by 5.62% YoY to 70.5%.
Ascendiant analyst Edward Woo initiated coverage with a Buy rating and a $5 price target, citing large market opportunities for the company's products.
